Metanoa is a Health Care startup founded in 2019 and based in India. Their slogan "We embrace technology to assess a child’s risk for Autism in early stages and enabling them reach a normal social life" underscores their commitment to leveraging technology for early identification and intervention in developmental disorders. Metanoa's software platform comprises a mobile application for parents and a web application for clinics & schools. The mobile app enables parents to track their child's development from birth, facilitating early identification of developmental delays. If a disorder is detected, the system provides home-based therapy recommendations and continuously monitors progress, ensuring timely intervention. The web app streamlines administrative tasks for clinics and schools, empowering therapists and educators to dedicate more time to patient care, leading to cost savings and improved operational efficiencies. Metanoa's unique features include integrated screening tools, automated report generation, and AI-based therapy recommendations, accelerating the therapy process. Their proactive approach, coupled with technology-driven solutions, not only improves the quality of life for individuals with developmental disorders but also addresses the accessibility and quality of care. With their innovative solutions, Metanoa is poised to make a significant impact in the health tech space, presenting an attractive investment opportunity for venture capitalists seeking impactful and scalable solutions in the healthcare sector.
There is no investment information